Cegedim SA (EPA:ALCGM)
France
· Delayed Price · Currency is EUR | Market Cap | 160.40M |
| Revenue (ttm) | 649.17M |
| Net Income (ttm) | 9.40M |
| Shares Out | 13.77M |
| EPS (ttm) | 0.68 |
| PE Ratio | 17.05 |
| Forward PE | 5.52 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 6,927 |
| Average Volume | 20,752 |
| Open | 12.00 |
| Previous Close | 11.65 |
| Day's Range | 11.50 - 12.00 |
| 52-Week Range | 8.50 - 15.30 |
| Beta | 0.62 |
| RSI | 48.27 |
| Earnings Date | Sep 24, 2026 |
About Cegedim
Cegedim SA operates as a technology and services company in the field of digital data flow management for healthcare ecosystem and B2B in France, rest of Europe, and internationally. It operates through Health Insurance, HR and E-Services; Healthcare Professionals; and Cloud & Support segments. The Health Insurance, HR and E-Services segment markets various products and services to insurance companies, mutual insurers, personal protection insurers, and insurance brokers, as well as engages in the interactions between these entities and healthca... [Read more]
Financial Performance
Financial StatementsNews
Cegedim: Like-for-Like Revenues Fell 0.8% in the First Quarter of 2026
First-quarter revenues of €159.6 million, down €1.7 million or -1.0% on a reported basisNo impact on full-year outlook of like-for-like growth above 2% BOULOGNE-BILLANCOURT, FRANCE / ACCESS Newswir...
Cegedim Earnings Call Transcript: Q1 2026
Q1 2026 revenue declined slightly due to tough comparisons in cloud and support, but growth was seen in business services and international health segments. Full-year guidance remains for over 2% like-for-like growth, with e-business expected to accelerate in 2027.
Cegedim: Release of its 2025 Universal Registration Document
BOULOGNE-BILLANCOURT, FR / ACCESS Newswire / April 17, 2026 / Cegedim, an innovative technology and services company, announces that its 2025 Universal Registration Document (in French) has been publi...
Full Year 2025 Cegedim SA Earnings Call Transcript
Full Year 2025 Cegedim SA Earnings Call Transcript
Cegedim Earnings Call Transcript: H2 2025
Adjusted operating income rose 25% to €49.4M with margin up to 7.6%, while net income swung to €8.3M from a loss last year. Strong cost control and tax reimbursement drove results, with net debt reduced by 25%.
Cegedim Earnings Call Transcript: Q4 2025
Full year 2025 revenue was €649.2M, up 1.1% like-for-like, with strong HR, e-business, and insurance segments offset by pharmacy reorganization and deconsolidation impacts. Adjusted operating income is targeted to grow at least 15%, with 2026 revenue growth expected at 2–4%.
Half Year 2025 Cegedim SA Earnings Call Transcript
Half Year 2025 Cegedim SA Earnings Call Transcript
Cegedim Earnings Call Transcript: Q3 2025
Q3 revenue declined 2% reported but grew 0.5% like-for-like, with nine-month growth at 2.1%. Full-year guidance is maintained, with adjusted operating income and EBIT expected to improve, driven by strong cloud, HR software, and insurance segments.
Cegedim Earnings Call Transcript: H1 2025
Revenue grew 1.1% to EUR 322.5 million in H1 2025, with adjusted operating income up 78% and strong cash flow reducing net debt by 15%. Restructuring in the pharmacy segment and the sale of In Practice Systems impacted non-recurring items, while all divisions reported positive adjusted operating income.
Cegedim's profitability improving as expected in H1 2025
PRESS RELEASE First-half financial information as of June 30, 2025 IFRS - Regulated information - Not audited Cegedim's profitability improving as expected Revenue up 1.1% as reported and 2.8% LFL to ...
Cegedim Earnings Call Transcript: Q2 2025
Revenue grew 2.8% like-for-like in H1 2025, led by health insurance, HR, and digitalization. Major restructuring in pharmacy software will cut 100 jobs, with exceptional charges in H1. Outlook remains positive, with improved cash and EBIT expected post-restructuring.
Cegedim Earnings Call Transcript: Q1 2025
Q1 2025 revenue grew 3.5% reported and 4.5% like-for-like, driven by marketing, health insurance, HR, and cloud. Software and services faced headwinds from a renegotiated data contract, while Maiia bundles saw strong growth. EBIT margin improved with cost controls and removal of loss-making units.
Cegedim Earnings Call Transcript: H2 2024
Revenue grew 6.3% to €654.5M and recurring operating income rose 24.7%, but net income was a €14.7M loss due to non-cash impairments. Strong cash flow and segment growth were offset by exceptional items and increased net debt from acquisitions.
Cegedim Earnings Call Transcript: Q4 2024
2024 revenue grew 6.3% to €654.5M, with all divisions contributing and strong Q4 momentum. The exit from UK physician software will reduce 2025 growth to 1–2% reported, but cost savings and margin focus are expected to improve profitability, with a projected 5.5% EBIT margin.
Cegedim Earnings Call Transcript: Q3 2024
Nine-month revenue grew 5.9% reported and 4.3% like-for-like, with all divisions except Software and Services contributing positively. Full-year growth is expected at the lower end of guidance, as UK market exit and absence of subsidies weigh on results.
Cegedim Earnings Call Transcript: H1 2024
Revenue grew 6% to €319M in H1 2024, with EBITDA up 6.9% and margin at 16.4%. Recurring operating income declined due to higher R&D amortization, while net profit was nearly breakeven. H2 is expected to be stronger, with improved profitability from the Allianz contract and continued focus on cost control.
Cegedim Earnings Call Transcript: Q2 2024
First half revenue grew 6% reported to €319 million, with strong gains in BPO, cloud, and marketing, while software and international data businesses faced headwinds. Full-year guidance of 5%-8% growth and higher recurring operating income is maintained.